Enhancement of Dendritic Cell Production by Fms-Like Tyrosine Kinase-3 Ligand Increases the Resistance of Mice to a Burn Wound Infection

Fms-like tyrosine kinase-3 ligand (Flt3L) is a hemopoietic cytokine that stimulates the production of dendritic cells. This study evaluated the ability of Flt3L-enhanced dendritic cell production to increase the resistance of mice to a burn wound infection with Pseudomonas aeruginosa, a common sourc...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 174; no. 1; pp. 404 - 410
Main Authors Toliver-Kinsky, Tracy E, Cui, Weihua, Murphey, Erle D, Lin, Chengyie, Sherwood, Edward R
Format Journal Article
LanguageEnglish
Published United States Am Assoc Immnol 01.01.2005
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Fms-like tyrosine kinase-3 ligand (Flt3L) is a hemopoietic cytokine that stimulates the production of dendritic cells. This study evaluated the ability of Flt3L-enhanced dendritic cell production to increase the resistance of mice to a burn wound infection with Pseudomonas aeruginosa, a common source of infections in burn patients that have impaired immunity and are susceptible to opportunistic microorganisms. Treatment of mice with Flt3L for 5 days caused a significant increase in dendritic cell numbers in the spleen and significantly increased survival upon a subsequent burn wound infection. Improved survival in Flt3L-treated mice was associated with limited bacterial growth and spread within the burn wounds and a decrease in systemic dissemination of P. aeruginosa. Resistance to burn wound infection could also be conferred to recipient mice by the adoptive transfer of dendritic cells that had been isolated from spleens of Flt3L-treated mice. Adoptive transfer of the same number of splenic dendritic cells from nontreated mice did not confer resistance to burn wound infection. These data indicate that Flt3L can increase the resistance of mice to a P. aeruginosa burn wound infection through both stimulation of dendritic cell production and enhancement of dendritic cell function.
AbstractList Fms-like tyrosine kinase-3 ligand (Flt3L) is a hemopoietic cytokine that stimulates the production of dendritic cells. This study evaluated the ability of Flt3L-enhanced dendritic cell production to increase the resistance of mice to a burn wound infection with Pseudomonas aeruginosa, a common source of infections in burn patients that have impaired immunity and are susceptible to opportunistic microorganisms. Treatment of mice with Flt3L for 5 days caused a significant increase in dendritic cell numbers in the spleen and significantly increased survival upon a subsequent burn wound infection. Improved survival in Flt3L-treated mice was associated with limited bacterial growth and spread within the burn wounds and a decrease in systemic dissemination of P. aeruginosa. Resistance to burn wound infection could also be conferred to recipient mice by the adoptive transfer of dendritic cells that had been isolated from spleens of Flt3L-treated mice. Adoptive transfer of the same number of splenic dendritic cells from nontreated mice did not confer resistance to burn wound infection. These data indicate that Flt3L can increase the resistance of mice to a P. aeruginosa burn wound infection through both stimulation of dendritic cell production and enhancement of dendritic cell function.
Abstract Fms-like tyrosine kinase-3 ligand (Flt3L) is a hemopoietic cytokine that stimulates the production of dendritic cells. This study evaluated the ability of Flt3L-enhanced dendritic cell production to increase the resistance of mice to a burn wound infection with Pseudomonas aeruginosa, a common source of infections in burn patients that have impaired immunity and are susceptible to opportunistic microorganisms. Treatment of mice with Flt3L for 5 days caused a significant increase in dendritic cell numbers in the spleen and significantly increased survival upon a subsequent burn wound infection. Improved survival in Flt3L-treated mice was associated with limited bacterial growth and spread within the burn wounds and a decrease in systemic dissemination of P. aeruginosa. Resistance to burn wound infection could also be conferred to recipient mice by the adoptive transfer of dendritic cells that had been isolated from spleens of Flt3L-treated mice. Adoptive transfer of the same number of splenic dendritic cells from nontreated mice did not confer resistance to burn wound infection. These data indicate that Flt3L can increase the resistance of mice to a P. aeruginosa burn wound infection through both stimulation of dendritic cell production and enhancement of dendritic cell function.
Author Lin, Chengyie
Cui, Weihua
Toliver-Kinsky, Tracy E
Murphey, Erle D
Sherwood, Edward R
Author_xml – sequence: 1
  fullname: Toliver-Kinsky, Tracy E
– sequence: 2
  fullname: Cui, Weihua
– sequence: 3
  fullname: Murphey, Erle D
– sequence: 4
  fullname: Lin, Chengyie
– sequence: 5
  fullname: Sherwood, Edward R
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15611264$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1OGzEUhS0EKgH6Aiwqr7qb4J-xnSzblD8RBEJUXVoezx1iOmODPaMob9DHxgNBWXZ1pKNzPsv3HKF9HzwgdErJtCTl_OzZdd3gQzulqpzS0dtDEyoEKaQkch9NCGGsoEqqQ3SU0jMhRBJWfkGHVEhKmSwn6N-5XxlvoQPf49DgX-Dr6Hpn8QLaFt_HUA-2d8HjaoMvulQs3V_Aj5sYkvOAb5w3CQqOl-7J-BpfexshOwn3K8APkFzqR_yIvnVZ-4AN_jlEj_-E4b3QwDv_BB00pk3wdavH6PfF-ePiqljeXV4vfiwLKxjrCzu3RlnLZlktIaBoTWsDnBnFm8oyYkBWFRVzMxNzMQPF6pmUqqk4V8xaw4_R9w_uSwyvA6Redy7Z_FfjIQxJS8U5U6X4b5AqJRTlMgfZR9Dmo6QIjX6JrjNxoynR41D6c6jcKTUdvVz6tqUPVQf1rrJdZvf8yj2t1i6CTp1p2xyner1e70hv_nGhXw
CitedBy_id crossref_primary_10_1097_SHK_0000000000000964
crossref_primary_10_1517_14712598_7_7_929
crossref_primary_10_1016_j_legalmed_2014_01_008
crossref_primary_10_1007_s00540_014_1882_y
crossref_primary_10_3109_13693786_2010_509744
crossref_primary_10_1128_IAI_01299_10
crossref_primary_10_1016_j_cellimm_2011_06_020
crossref_primary_10_1016_j_cpem_2014_04_002
crossref_primary_10_1016_j_intimp_2023_110738
crossref_primary_10_3389_fimmu_2023_1113948
crossref_primary_10_1097_SHK_0b013e31819e2937
crossref_primary_10_1007_s10753_013_9753_5
crossref_primary_10_1007_s10753_009_9156_9
crossref_primary_10_1152_ajplung_00408_2006
crossref_primary_10_1016_j_jss_2013_09_042
crossref_primary_10_1152_ajpcell_00337_2019
crossref_primary_10_1371_journal_pone_0159624
crossref_primary_10_1016_j_cpsurg_2020_100779
crossref_primary_10_1186_s12986_021_00592_x
crossref_primary_10_1189_jlb_0212072
crossref_primary_10_1038_nri3552
crossref_primary_10_1097_SHK_0b013e31815abe80
crossref_primary_10_1097_XCS_0000000000000119
crossref_primary_10_1111_j_1365_2249_2012_04641_x
crossref_primary_10_1111_imm_13320
crossref_primary_10_1371_journal_pone_0148452
crossref_primary_10_4049_jimmunol_181_12_8513
crossref_primary_10_3390_ijms23052444
crossref_primary_10_1016_j_ajpath_2012_06_039
crossref_primary_10_1016_j_intimp_2018_03_002
crossref_primary_10_1371_journal_ppat_1007360
crossref_primary_10_1021_acsami_6b00291
crossref_primary_10_1038_s41598_017_16869_2
crossref_primary_10_1097_01_shk_0000238069_84826_1b
crossref_primary_10_1155_2015_903720
crossref_primary_10_1016_j_immuni_2021_02_004
crossref_primary_10_1002_bab_1027
crossref_primary_10_1189_jlb_1A0815_377R
crossref_primary_10_1097_CCM_0000000000000879
crossref_primary_10_1189_jlb_0408257
crossref_primary_10_1097_SHK_0b013e3181ce2be8
crossref_primary_10_1016_j_coph_2014_07_013
crossref_primary_10_1097_01_BCR_0000238083_95170_2A
crossref_primary_10_2119_molmed_2009_00048
crossref_primary_10_1097_SHK_0b013e31829aef41
crossref_primary_10_14336_AD_2020_0627
crossref_primary_10_1016_j_molimm_2018_07_007
crossref_primary_10_1113_JP274841
crossref_primary_10_1111_imm_12423
crossref_primary_10_2119_2007_00102_Monneret
crossref_primary_10_1093_jbcr_irz007
crossref_primary_10_1186_s12865_016_0188_2
crossref_primary_10_1016_j_vaccine_2008_06_044
crossref_primary_10_4049_jimmunol_0903619
crossref_primary_10_4049_jimmunol_180_5_3038
crossref_primary_10_1111_nyas_14333
crossref_primary_10_1186_1471_2172_10_47
crossref_primary_10_1016_j_cyto_2008_10_005
crossref_primary_10_1016_j_legalmed_2013_10_002
crossref_primary_10_1111_wrr_12388
crossref_primary_10_1016_j_ccm_2008_06_010
crossref_primary_10_1007_s00018_009_0251_8
crossref_primary_10_4049_jimmunol_1601463
crossref_primary_10_1016_j_medin_2009_11_005
crossref_primary_10_1007_s11481_018_9819_0
crossref_primary_10_1038_s41598_018_21282_4
crossref_primary_10_1189_jlb_4A0815_362R
crossref_primary_10_1097_BCR_0b013e318171122c
Cites_doi 10.4049/jimmunol.171.8.3983
10.1097/00005373-199803000-00008
10.1016/S1567-5769(01)00122-9
10.1016/S0301-472X(01)00722-6
10.1002/(SICI)1097-0320(20000501)40:1<50::AID-CYTO7>3.0.CO;2-P
10.1128/IAI.71.6.3058-3067.2003
10.1097/00006454-200010000-00010
10.1007/BF00952962
10.1177/000313480006600220
10.1084/jem.20030323
10.1002/jlb.61.5.575
10.1097/00006534-200204010-00020
10.1097/00004630-199211000-00002
10.1084/jem.188.11.2075
10.4049/jimmunol.171.1.325
10.1084/jem.20021900
10.1242/jeb.200.14.2057
10.1128/iai.44.3.554-558.1984
10.4049/jimmunol.171.2.909
10.1002/eji.200324336
10.1517/14656566.4.3.369
10.4049/jimmunol.170.10.5075
10.1001/archsurg.134.12.1317
10.1002/eji.200324443
10.1097/00005373-199512000-00023
10.1182/blood.V96.3.878.015k15_878_884
10.1001/archsurg.133.7.715
10.1097/00000658-199522240-00006
10.1084/jem.176.4.1215
10.4049/jimmunol.161.6.2817
10.1084/jem.189.12.1981
10.4049/jimmunol.172.7.4077
10.1128/IAI.67.11.5854-5862.1999
10.1046/j.1365-2567.2001.01180.x
10.1016/S0305-4179(01)00070-5
10.1038/7403
10.1002/eji.1830260603
10.1097/00024382-200014030-00005
10.1164/rccm.200208-950OC
10.4049/jimmunol.167.3.1179
10.1097/00004630-199511000-00003
10.1182/blood.V95.11.3489.011k45_3489_3497
10.1002/bjs.1800820618
10.1128/IAI.69.2.673-680.2001
10.1097/00024382-200210000-00006
10.1515/CCLM.1999.036
10.1097/00005373-198902000-00007
10.1182/blood.V97.11.3333
10.4049/jimmunol.168.5.2493
10.1016/S0165-2478(03)00151-2
10.4049/jimmunol.170.12.6355
10.1001/archsurg.1991.01410250080013
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
H94
7X8
DOI 10.4049/jimmunol.174.1.404
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
AIDS and Cancer Research Abstracts
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1550-6606
EndPage 410
ExternalDocumentID 10_4049_jimmunol_174_1_404
15611264
www174_1_404
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
08R
2WC
34G
39C
3O-
53G
55
5GY
5RE
5VS
79B
85S
8RP
AALRV
AARDX
ABEFU
ABFLS
ABOCM
ABPPZ
ABPTK
ACGFS
ACIWK
ACNCT
ACPRK
ADACO
ADBBV
ADKFC
AENEX
AETEA
AFFNX
AFRAH
AJYGW
ALMA_UNASSIGNED_HOLDINGS
BAWUL
D0L
DIK
DU5
E3Z
EBS
EJD
F5P
FH7
FRP
G8K
GJ
GX1
H13
IH2
J5H
K-O
K78
KQ8
L7B
MVM
MYA
NEJ
O0-
OK1
P0W
P2P
PQEST
PQQKQ
R.V
RHF
RHI
RZQ
SJN
TWZ
VH1
WH7
WOQ
X
X7M
XJT
ZA5
ZE2
ZGI
---
-~X
.55
.GJ
18M
ABCQX
ABJNI
ACGFO
ADNWM
AFHIN
AFOSN
AHWXS
AI.
AIZAD
BTFSW
CGR
CUY
CVF
ECM
EIF
NPM
TR2
W8F
XSW
XTH
YHG
AAYXX
CITATION
7T5
H94
7X8
ABDPE
ID FETCH-LOGICAL-c522t-c9ca7cc289cac00e71d1dae32a73fbc20ae6bb159a85958e72d8667fb3372cca3
ISSN 0022-1767
IngestDate Sat Oct 26 00:47:16 EDT 2024
Fri Oct 25 07:04:44 EDT 2024
Thu Sep 26 18:30:21 EDT 2024
Sat Sep 28 08:38:37 EDT 2024
Tue Nov 10 19:21:06 EST 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c522t-c9ca7cc289cac00e71d1dae32a73fbc20ae6bb159a85958e72d8667fb3372cca3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://journals.aai.org/jimmunol/article-pdf/174/1/404/1192509/404.pdf
PMID 15611264
PQID 17757136
PQPubID 23462
PageCount 7
ParticipantIDs proquest_miscellaneous_67332745
proquest_miscellaneous_17757136
crossref_primary_10_4049_jimmunol_174_1_404
pubmed_primary_15611264
highwire_smallpub1_www174_1_404
ProviderPackageCode RHF
RHI
PublicationCentury 2000
PublicationDate 20050101
2005-Jan-01
2005-01-01
PublicationDateYYYYMMDD 2005-01-01
PublicationDate_xml – month: 01
  year: 2005
  text: 20050101
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of immunology (1950)
PublicationTitleAlternate J Immunol
PublicationYear 2005
Publisher Am Assoc Immnol
Publisher_xml – name: Am Assoc Immnol
References 2023010119261719100_R34
2023010119261719100_R35
2023010119261719100_R32
2023010119261719100_R33
2023010119261719100_R38
2023010119261719100_R39
2023010119261719100_R36
2023010119261719100_R37
2023010119261719100_R30
2023010119261719100_R31
2023010119261719100_R45
2023010119261719100_R46
2023010119261719100_R43
2023010119261719100_R44
2023010119261719100_R49
2023010119261719100_R47
2023010119261719100_R48
2023010119261719100_R41
2023010119261719100_R42
2023010119261719100_R40
2023010119261719100_R12
2023010119261719100_R56
2023010119261719100_R13
2023010119261719100_R10
2023010119261719100_R54
2023010119261719100_R11
2023010119261719100_R55
2023010119261719100_R16
2023010119261719100_R17
2023010119261719100_R14
2023010119261719100_R15
2023010119261719100_R52
2023010119261719100_R53
2023010119261719100_R50
2023010119261719100_R51
2023010119261719100_R18
2023010119261719100_R19
2023010119261719100_R23
2023010119261719100_R24
2023010119261719100_R21
2023010119261719100_R22
2023010119261719100_R27
2023010119261719100_R28
2023010119261719100_R25
2023010119261719100_R26
2023010119261719100_R9
2023010119261719100_R20
2023010119261719100_R2
2023010119261719100_R1
2023010119261719100_R4
2023010119261719100_R3
2023010119261719100_R6
2023010119261719100_R5
2023010119261719100_R8
2023010119261719100_R7
2023010119261719100_R29
References_xml – ident: 2023010119261719100_R27
  doi: 10.4049/jimmunol.171.8.3983
– ident: 2023010119261719100_R26
  doi: 10.1097/00005373-199803000-00008
– ident: 2023010119261719100_R48
  doi: 10.1016/S1567-5769(01)00122-9
– ident: 2023010119261719100_R49
  doi: 10.1016/S0301-472X(01)00722-6
– ident: 2023010119261719100_R31
  doi: 10.1002/(SICI)1097-0320(20000501)40:1<50::AID-CYTO7>3.0.CO;2-P
– ident: 2023010119261719100_R22
  doi: 10.1128/IAI.71.6.3058-3067.2003
– ident: 2023010119261719100_R1
  doi: 10.1097/00006454-200010000-00010
– ident: 2023010119261719100_R36
  doi: 10.1007/BF00952962
– ident: 2023010119261719100_R28
  doi: 10.1177/000313480006600220
– ident: 2023010119261719100_R20
  doi: 10.1084/jem.20030323
– ident: 2023010119261719100_R8
  doi: 10.1002/jlb.61.5.575
– ident: 2023010119261719100_R25
  doi: 10.1097/00006534-200204010-00020
– ident: 2023010119261719100_R9
  doi: 10.1097/00004630-199211000-00002
– ident: 2023010119261719100_R50
  doi: 10.1084/jem.188.11.2075
– ident: 2023010119261719100_R4
– ident: 2023010119261719100_R51
  doi: 10.4049/jimmunol.171.1.325
– ident: 2023010119261719100_R40
  doi: 10.1084/jem.20021900
– ident: 2023010119261719100_R33
  doi: 10.1242/jeb.200.14.2057
– ident: 2023010119261719100_R5
  doi: 10.1128/iai.44.3.554-558.1984
– ident: 2023010119261719100_R56
  doi: 10.4049/jimmunol.171.2.909
– ident: 2023010119261719100_R35
  doi: 10.1002/eji.200324336
– ident: 2023010119261719100_R16
  doi: 10.1517/14656566.4.3.369
– ident: 2023010119261719100_R43
  doi: 10.4049/jimmunol.170.10.5075
– ident: 2023010119261719100_R10
– ident: 2023010119261719100_R13
  doi: 10.1001/archsurg.134.12.1317
– ident: 2023010119261719100_R39
  doi: 10.1002/eji.200324443
– ident: 2023010119261719100_R17
  doi: 10.1097/00005373-199512000-00023
– ident: 2023010119261719100_R24
  doi: 10.1182/blood.V96.3.878.015k15_878_884
– ident: 2023010119261719100_R30
  doi: 10.1001/archsurg.133.7.715
– ident: 2023010119261719100_R6
  doi: 10.1097/00000658-199522240-00006
– ident: 2023010119261719100_R46
  doi: 10.1084/jem.176.4.1215
– ident: 2023010119261719100_R23
  doi: 10.4049/jimmunol.161.6.2817
– ident: 2023010119261719100_R45
  doi: 10.1084/jem.189.12.1981
– ident: 2023010119261719100_R38
  doi: 10.4049/jimmunol.172.7.4077
– ident: 2023010119261719100_R29
  doi: 10.1128/IAI.67.11.5854-5862.1999
– ident: 2023010119261719100_R52
  doi: 10.1046/j.1365-2567.2001.01180.x
– ident: 2023010119261719100_R2
  doi: 10.1016/S0305-4179(01)00070-5
– ident: 2023010119261719100_R32
– ident: 2023010119261719100_R42
  doi: 10.1038/7403
– ident: 2023010119261719100_R47
  doi: 10.1002/eji.1830260603
– ident: 2023010119261719100_R11
  doi: 10.1097/00024382-200014030-00005
– ident: 2023010119261719100_R34
  doi: 10.1164/rccm.200208-950OC
– ident: 2023010119261719100_R44
  doi: 10.4049/jimmunol.167.3.1179
– ident: 2023010119261719100_R3
  doi: 10.1097/00004630-199511000-00003
– ident: 2023010119261719100_R21
  doi: 10.1182/blood.V95.11.3489.011k45_3489_3497
– ident: 2023010119261719100_R18
  doi: 10.1002/bjs.1800820618
– ident: 2023010119261719100_R53
  doi: 10.1128/IAI.69.2.673-680.2001
– ident: 2023010119261719100_R15
  doi: 10.1097/00024382-200210000-00006
– ident: 2023010119261719100_R12
– ident: 2023010119261719100_R14
  doi: 10.1515/CCLM.1999.036
– ident: 2023010119261719100_R7
  doi: 10.1097/00005373-198902000-00007
– ident: 2023010119261719100_R37
  doi: 10.1182/blood.V97.11.3333
– ident: 2023010119261719100_R55
  doi: 10.4049/jimmunol.168.5.2493
– ident: 2023010119261719100_R41
  doi: 10.1016/S0165-2478(03)00151-2
– ident: 2023010119261719100_R54
  doi: 10.4049/jimmunol.170.12.6355
– ident: 2023010119261719100_R19
  doi: 10.1001/archsurg.1991.01410250080013
SSID ssj0006024
Score 2.1380029
Snippet Fms-like tyrosine kinase-3 ligand (Flt3L) is a hemopoietic cytokine that stimulates the production of dendritic cells. This study evaluated the ability of...
Abstract Fms-like tyrosine kinase-3 ligand (Flt3L) is a hemopoietic cytokine that stimulates the production of dendritic cells. This study evaluated the...
SourceID proquest
crossref
pubmed
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 404
SubjectTerms Adoptive Transfer
Animals
Burns - complications
Cell Count
Dendritic Cells - cytology
Dendritic Cells - immunology
Flow Cytometry
fms-Like Tyrosine Kinase 3
Humans
Ligands
Mice
Proto-Oncogene Proteins - metabolism
Pseudomonas aeruginosa
Pseudomonas Infections - etiology
Pseudomonas Infections - prevention & control
Receptor Protein-Tyrosine Kinases - metabolism
Spleen - cytology
Wound Infection - etiology
Wound Infection - prevention & control
Title Enhancement of Dendritic Cell Production by Fms-Like Tyrosine Kinase-3 Ligand Increases the Resistance of Mice to a Burn Wound Infection
URI http://www.jimmunol.org/cgi/content/abstract/174/1/404
https://www.ncbi.nlm.nih.gov/pubmed/15611264
https://search.proquest.com/docview/17757136
https://search.proquest.com/docview/67332745
Volume 174
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LjtMwFLXKIBAbBMOrw8sLWEUpeTtdIlQYIYZVR3QXOY4zEyZNRpNEVecL-A9-lHvjOEkHKgGbqHIiJ805uT6274OQN6llycR2UlOCnjdB34ZmHIYeCLnUDwUQKHUwGvnka3B86n1e-avJ5OfIa6mp45m4_mNcyf-gCm2AK0bJ_gOyfafQAL8BXzgCwnD8K4wXxTmCpvfzwYQkbeUCA5fj0fUqUblhUWOm68rMswtp1FsYGFFbXmQFDGGma-TZmcrBhAqywpwP6HYoK5SW-N3jFjzYE5Sp3AAQCmODxZh6R65irHCHWDOVjgLjT1Sep7ftbpo1WntYljm6hWAJ424NF4ZOsR1FRzSts8E3mZ03fIcbaqV9cZXLwWf5S9Z5EMjibJvJnQUNf7SgMQQY2ExV6eiNtKrls8NGZXI9Vb745lAAzZhJ9Xv3N9Fxa2bPblwMcF6uW3LANBaDqbxhWOydFfWpW-S2A9YMzein1eBHFFiOp1PS41OryCy8_bvfb95WgVLd7QohnZx6_0SnFTzLB-R-hyF9r2j3kExkcUjuqNql20Ny96TzynhEfox4SMuU9jykyEM68JDGW6p5SDUPqeYhVTykPQ8p8JAOPMSukYe0LimnyEPa8pD2PHxMTj8ulh-Oza7ChylA99emmAvOhIBJv-ACrAazEzvh0nU4c9NYOBaXQRyD4uaYhi-UzEnCIGBp7LrMAdvjPiEHRVnIZ4QGODWxQI0nCfNiGcx9Jn1fJHwu5BwMzpQY-nVHlyqRSwQTYMQp0jhFgFNkY9uUvNaIRNWa5zkgYUebzWZ8hQYqAouM75MXsmwq6IT5zHaD_VcEzHUd5vlT8lQhPDxRR46jvWeek3vDR_OCHNRXjXwJuriOX7W8_AXA3bty
link.rule.ids 315,783,787,27936,27937
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Enhancement+of+dendritic+cell+production+by+fms-like+tyrosine+kinase-3+ligand+increases+the+resistance+of+mice+to+a+burn+wound+infection&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Toliver-Kinsky%2C+Tracy+E&rft.au=Cui%2C+Weihua&rft.au=Murphey%2C+Erle+D&rft.au=Lin%2C+Chengyie&rft.date=2005-01-01&rft.issn=0022-1767&rft.volume=174&rft.issue=1&rft.spage=404&rft_id=info:doi/10.4049%2Fjimmunol.174.1.404&rft_id=info%3Apmid%2F15611264&rft.externalDocID=15611264
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon